| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Hansen Gwenn is a Chief Scientific Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $45.00 | $36,000.00 | -5.5% | -34.9% | -69.3% | |
| Mar 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $35.95 | $28,760.00 | -5.5% | - | - | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $36.27 | $29,018.02 | -3.2% | - | - |